Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
To verify the non-inferiority of exemestane compared to anastrozole in time to tumor
progression (TTP), the primary efficacy endpoint, in postmenopausal women with
advanced/recurrent breast cancer.